Related Experiment Video
Updated: Sep 29, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
Effect of melatonin in children with neurodevelopmental disabilities and sleep disorders
Waleed A Al Twaijri1, Dua'a Ba Armah1, Najla Bin Sabbar1
1Pediatric Neurology Division, Department of Pediatric, King Abdullah Children Specialist Hospital, National Guard Health Affairs, Riyadh, Saudi Arabia.
Insights
Melatonin significantly improved sleep quality and duration in children with neurodevelopmental disabilities and sleep disorders. This study found positive impacts on falling asleep, nighttime awakenings, and overall sleep time without major side effects.
Area of Science:
- Pediatric Neurology
- Sleep Medicine
- Developmental Pediatrics
Background:
- Sleep disorders are common in children with neurodevelopmental disabilities.
- These sleep disturbances can negatively impact development and quality of life.
- Melatonin is a potential therapeutic option for managing sleep issues in this population.
Purpose of the Study:
- To evaluate the effectiveness of melatonin in improving sleep in children with neurodevelopmental disabilities.
- To assess the safety and side effects of melatonin treatment in this specific pediatric group.
Main Methods:
- A cross-sectional study was conducted in a pediatric neurology clinic.
- Parental questionnaires were used to gather data on sleep patterns before and after melatonin use.
- Demographic data and sleep parameters were collected and analyzed.
Main Results:
- Twenty-three children with neurodevelopmental disabilities and sleep disorders participated.
- Melatonin showed significant improvements in time to fall asleep, reduced nighttime awakenings, increased total sleep time, and improved wake-up time.
- No major adverse effects were reported during the study.
Conclusions:
- Melatonin demonstrated a significant positive impact on sleep quality and duration in children with neurodevelopmental disabilities.
- The findings support melatonin as an effective and safe intervention for sleep disorders in this vulnerable population.
Objectives:
The aim of this study is to assess the efficacy and side effects of melatonin use in a population of children with neurodevelopmental disabilities who had sleep disorders.
Methods:
This is a cross-sectional study conducted in the pediatric neurology clinic at King Abdulaziz Medical City. A designed questionnaire was given to the parents to inquire about the sleep characteristics of their children before and after using melatonin. The patients' demographic data were collected and different parameters before and after starting melatonin were compared. Categorical variables were summarized and reported in terms of frequency and percent (n%). Continuous variables were reported in terms of mean and standard deviation.
Results:
A total of 23 patients were enrolled in our study, of which 15 (65.22%) were male. The mean age was 5.83 ± 3.07 years. For melatonin dose, 9 (39.13%) received 1 mg, 8 (34.78%) received 2 mg, and 6 (26.09%) received over 3 mg. Regarding melatonin duration of use, 7 (30.43%) received melatonin for 0 to 6 months, 7 (30.43%) received it for 7 to 12 months, and 9 (39.13%) received it for over a year. Significant differences were observed in time taken to fall asleep (P =0.046), the number of times the child woke up at night (P =0.071), total sleep time within 24 hours (P =.011), and time taken to wake up (P =.007), while no significant difference was observed in the number of naps taken during the daytime (P =.801). There were no major side effects reported.
Conclusion:
Melatonin had a significant impact on total sleep time and quality during the pre and post assessment of children with neurodevelopmental disabilities and sleep disorders.
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
Nightmares and Night Terrors
Nightmares...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
REM Sleep Behavior Disorder
RBD is significantly associated with...

